Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Total Debt (2023 - 2024)

Historic Total Debt for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Q4 2024 value amounting to $7.5 million.

  • Tonix Pharmaceuticals Holding's Total Debt fell 1598.02% to $7.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $7.5 million, marking a year-over-year decrease of 1598.02%. This contributed to the annual value of $7.5 million for FY2024, which is 1598.02% down from last year.
  • Per Tonix Pharmaceuticals Holding's latest filing, its Total Debt stood at $7.5 million for Q4 2024, which was down 1598.02% from $8.0 million recorded in Q3 2024.
  • Tonix Pharmaceuticals Holding's Total Debt's 5-year high stood at $9.0 million during Q1 2024, with a 5-year trough of $7.5 million in Q4 2024.